Sequoia Financial Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-42,907	Closed	-$37K	–	392
2020 Q2	$37K	Sell	42,907 -25,814	-38%	-$22.7K	﹤0.01%	364
2020 Q1	$57K	Hold	68,721	–	–	﹤0.01%	355
2019 Q4	$61K	Buy	+68,721	New	+$57.2K	﹤0.01%	375
2019 Q3	–	Sell	-68,721	Closed	-$76K	–	374
2019 Q2	$76K	Sell	68,721 -14	-0%	-$16	0.01%	366
2019 Q1	$90K	Buy	68,735 +35	+0.1%	+$44	0.01%	359
2018 Q4	$63K	Sell	68,700 -14,110	-17%	-$21.6K	0.01%	287
2018 Q3	$170K	Buy	82,810 +33,775	+69%	+$70.9K	0.02%	303
2018 Q2	$88K	Sell	49,035 -6,953	-12%	-$14K	0.01%	298
2018 Q1	$132K	Hold	55,988	–	–	0.01%	294
2017 Q4	$105K	Hold	55,988	–	–	0.01%	296
2017 Q3	$139K	Hold	55,988	–	–	0.02%	275
2017 Q2	$154K	Hold	55,988	–	–	0.02%	270
2017 Q1	$169K	Hold	55,988	–	–	0.02%	271
2016 Q4	$177K	Hold	55,988	–	–	0.03%	259
2016 Q3	$191K	Hold	55,988	–	–	0.04%	229
2016 Q2	$128K	Sell	55,988 -641	-1%	-$1.57K	0.04%	239
2016 Q1	$142K	Buy	56,629 +997	+2%	+$2.23K	0.05%	187
2015 Q4	$184K	Hold	55,632	–	–	0.07%	165
2015 Q3	$135K	Buy	+55,632	New	+$144K	0.06%	166